United States Biosurgery Market Insight
Published: 15 June 2026 | Report Format: Electronic (PDF)
The United States Biosurgery Market is projected to grow at a CAGR of around 7.8%, driven by increasing surgical procedure volumes, rising adoption of advanced hemostatic and sealant products, expanding orthopedic and cardiovascular interventions, and continuous innovation in biologically derived surgical solutions
United States Biosurgery Market Forecasts to 2035
- The United States Biosurgery Market Size Was Estimated at USD 5.4 Billion in 2025.
- The Market Size is Expected to Grow at a CAGR of around 7.8% from 2025 to 2035.
- The United States Biosurgery Market Size is Expected to Reach around USD 11.5 Billion by 2035.
Notable Insights for the United States Biosurgery Market
- Segmentation Based on Product Type, hemostatic agents held a dominant position in 2025 with nearly 46% share, supported by their widespread utilization in cardiovascular, orthopedic, and general surgical procedures to effectively control bleeding.
- Segmentation Based on Application, general surgery accounted for approximately 34% share in 2025, driven by increasing inpatient surgical volumes, an aging population, and growing preference for advanced biosurgical products.
- The market is led by Johnson & Johnson, Baxter International Inc., and Medtronic plc; Johnson & Johnson reported approximately USD 89.55 billion revenue in FY2025, reinforcing its leadership across surgical technologies and biosurgery solutions.
- Baxter International Inc. generated approximately USD 10.64 billion revenue in FY2025, while Medtronic plc reported nearly USD 33.54 billion revenue, demonstrating the financial strength of leading biosurgery participants.
Download the eBook (ToC)
Research Methodologies Used to Analyze the United States Biosurgery Market
This study employs a combination of primary and secondary research methodologies to analyze the United States Biosurgery Market. Primary research includes interviews and discussions with biosurgery product manufacturers, surgeons, hospital procurement managers, ambulatory surgical center administrators, distributors, healthcare professionals, industry experts, and key stakeholders. Secondary research involves company annual reports, regulatory publications, government databases, scientific journals, investor presentations, white papers, and market intelligence sources. Market estimations are derived using both top-down and bottom-up approaches, while data triangulation and validation techniques ensure the accuracy and reliability of market forecasts, competitive assessments, and industry trends.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United States biosurgery market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Biosurgery Market
- Johnson & Johnson (Ethicon)
- Baxter International Inc.
- Medtronic plc
- Becton, Dickinson and Company
- Integra LifeSciences Holdings Corporation
- Stryker Corporation
- B. Braun Melsungen AG
- Advanced Medical Solutions Group plc
- CSL Limited
- CryoLife, Inc. (Artivion, Inc.)
Recent Developments:
- In September 2025, Baxter International Inc. launched an advanced hemostatic matrix designed to enhance bleeding control efficiency and improve surgical outcomes across complex inpatient procedures.
- In July 2025, Johnson & Johnson collaborated with a leading U.S. healthcare provider network to expand access to next-generation biosurgery solutions through clinical education and procedural optimization initiatives.
Market Segmentation:
United States Biosurgery Market, By Product Type
- Hemostatic Agents
- Surgical Sealants and Adhesives
- Adhesion Barriers
- Soft Tissue Attachments
- Bone Graft Substitutes
- Others
United States Biosurgery Market, By Application
- General Surgery
- Orthopedic Surgery
- Cardiovascular Surgery
- Neurological Surgery
- Gynecological Surgery
- Reconstructive Surgery
- Others
United States Biosurgery Market, By Source
- Biological Products
- Synthetic Products
- Semi-Synthetic Products
United States Biosurgery Market, By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Academic and Research Institutes
- Others
United States Biosurgery Market, By Distribution Channel
- Direct Tenders
- Third-Party Distributors
- Others
Expert Views:
The United States Biosurgery Market is expected to witness steady growth through 2035, supported by rising surgical volumes, increasing demand for effective bleeding management solutions, expanding adoption of advanced biosurgical technologies, and continued product launches and collaborations among leading industry participants, strengthening long-term market competitiveness and innovation.
Author: Sanket and Pranali By Decisions Advisors and Consulting